SPECTRACURE - Key Persons
Henrik Ljung has an MBA and has several years of experience as the CFO of Cerdo Bankpartner AB, Acconeer AB, Ballingslöv AB, Sardus AB, and Malmöhus Invest AB, among others.
Homer Pien was most recently SVP and Chief Scientific Officer for the Precision Diagnosis cluster of businesses, and prior to that Chief Technology Officer for Imaging System, at Philips. Before joining Philips in 2012, he was in the Department of Radiology at Massachusetts General Hospital and Harvard Medical School, where he led the Laboratory for Medical Imaging and Computations. Homer was also at two start-ups, one of which was a biotech company he co-founded and served as CEO before the company was acquired. Earlier in his career Homer was at MIT Lincoln Lab and Draper Lab. Homer has a PhD in computer science from Northeastern University (Boston, MA), and MS Management from Massachusetts Institute of Technology (Cambridge, MA).
Chairman Jan Karlsson, appointed by Masoud Khayyami, represents approximately 10.0 percent of shares and votes.
Jesper Freij is independent of the Company and the owners.
The new Board visited SpectraCure on Friday to get to know the Company and its management. The meeting was chaired by CEO Johan Folkunger, who welcomed the newly appointed Board, under the leadership of Jörgen Wennberg.
Johannes Swartling has a Ph.D. in physics from Lund University (2002). He has worked at SpectraCure since 2006 and is responsible for research and development at the company. He has experience in development of medical devices, clinical trials, and quality and regulatory work including risk management. Before joining SpectraCure AB, he held post-doctoral research positions at Politecnico di Milano, Italy, and at Cambridge University, UK. His research has been on applications of laser technology and spectroscopy in biology and medicine, His research has been on applications of laser technology and spectroscopy in biology and medicine, and he is the author of some 30 original peer-reviewed research papers.
Job Titles:
- Chairman of the Board since 2022
Jörgen Wennberg is independent of the Company and the owners.
Job Titles:
- Board Member of the Lund Laser Center
- Board Member since 2013
Katarina Svanberg is M.D., PhD and has for a long time been a consultant and adjunct professor of oncology at Lund University. She has previously been a part-time professor at South China Normal University in Guangzhou, China. Katarina has introduced photodynamic tumour therapy in clinical use at Lund University Hospital. She is the co-author of over 180 peer-reviewed articles and has, as the first woman in 41 years, been awarded with the National Institute of Health Lifetime Achievement Award in Biophotonics by the International Society for Optics and Photonics - the American Medical Board's award in laser medicine, and optics and laser organization SPIE's highest reward - its gold medal.
Katarina is a board member of the Lund Laser Center and has served since 1993, first as director and now as chairman of the board at Lund University Medical Laser Center.
Katarina Svanberg is independent of the Company and the owners.
Job Titles:
- Dentist
- HEAD of CLINICAL AFFAIRS
Kristina Holst is a licensed dentist. She has many years of experience in the medical technology industry and has mainly worked with clinical studies but also with marketing and product development. Kristina has previously held leading positions in clinical studies and regulatory activities at, among others, Arjo, Medeuronet, DMC Healthcare and Straumann.
Job Titles:
- Board Member since 2022
- Interim CEO
Masoud Khyyami has a PhD in technical chemistry and has solid experience from research in medical technology and biotechnology. He has previously been CEO of SpectraCure AB. Masoud has entrepreneurial experience in companies such as Lumito AB, Gasporox AB and Prolight Diagnostics AB. Today, Masoud works as CEO of Cardeon AB.
Tomas Kramar is independent of the Company and the owners.